 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
Health Economic Evaluation of Primovist-Enhanced Liver MRI
|
|
|
|
Phase IV
|
|
|
|
91789
312041, NCT00764621
|
|
| |
Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (= 75 Years)
|
|
|
|
Phase IV
|
|
|
|
I07028
N° EudraCT : 2008-001195-7, NCT00812864
|
|
| |
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
SP-11-0035
NCT00123760
|
|
| |
Promoting Colorectal Cancer Screening in Rural Colorado
|
|
|
|
Phase III, Phase II
|
|
|
|
CDC-NCCDPHP-4547
PRC SIP 20-04, NCT00137592
|
|
| |
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
|
|
|
|
Phase III, Phase II
|
|
|
|
AMT/P2CA/001
LC003AURON2005, NCT00332280
|
|
| |
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
|
|
|
|
Phase III, Phase II
|
|
|
|
D8480C00013
Eudract Number 2005-003440-66, NCT00384176
|
|
| |
Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003
|
|
|
|
Phase III, Phase II
|
|
|
|
AMT/P2GI/001 Part III
LC001Auron2005, NCT00405561
|
|
| |
Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Chemotherapy
|
|
|
|
Phase III, Phase II
|
|
|
|
CRAD001C2241
NCT00419159
|
|
| |
Flavonoids to Prevent Recurrence in Patients With Resected Colorectal Cancer or Colorectal Adenomas
|
|
|
|
Phase III, Phase II
|
|
|
|
Flav-Hoe-CCC
NCT00609310
|
|
| |
FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
STX0206
NCT00724503
|
|
